These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 15935415

  • 1. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ, Kuhmann SE, Morgan T, Herrera C, Rivera-Troche E, Xu S, Baroudy BM, Strizki J, Moore JP.
    Virology; 2005 Jul 20; 338(1):182-99. PubMed ID: 15935415
    [Abstract] [Full Text] [Related]

  • 2. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.
    Westby M, Smith-Burchnell C, Mori J, Lewis M, Mosley M, Stockdale M, Dorr P, Ciaramella G, Perros M.
    J Virol; 2007 Mar 20; 81(5):2359-71. PubMed ID: 17182681
    [Abstract] [Full Text] [Related]

  • 3. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K, Shibata J, Kimura T, Honda A, Maeda Y, Koito A, Murakami T, Mitsuya H, Matsushita S.
    AIDS; 2006 Oct 24; 20(16):2065-73. PubMed ID: 17053352
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry.
    Pugach P, Marozsan AJ, Ketas TJ, Landes EL, Moore JP, Kuhmann SE.
    Virology; 2007 Apr 25; 361(1):212-28. PubMed ID: 17166540
    [Abstract] [Full Text] [Related]

  • 5. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120.
    Ogert RA, Wojcik L, Buontempo C, Ba L, Buontempo P, Ralston R, Strizki J, Howe JA.
    Virology; 2008 Apr 10; 373(2):387-99. PubMed ID: 18190945
    [Abstract] [Full Text] [Related]

  • 6. Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5.
    Ogert RA, Hou Y, Ba L, Wojcik L, Qiu P, Murgolo N, Duca J, Dunkle LM, Ralston R, Howe JA.
    Virology; 2010 Apr 25; 400(1):145-55. PubMed ID: 20172579
    [Abstract] [Full Text] [Related]

  • 7. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L, Owen SM, Goldman I, Lal AA, deJong JJ, Goudsmit J, Lal RB.
    Virology; 1998 Jan 05; 240(1):83-92. PubMed ID: 9448692
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G.
    Virology; 1999 Nov 25; 264(2):370-84. PubMed ID: 10562499
    [Abstract] [Full Text] [Related]

  • 15. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK, Gali Y, El-Abdellati A, Heyndrickx L, Janssens W, Vanham G.
    Virology; 2006 Mar 30; 347(1):65-74. PubMed ID: 16386774
    [Abstract] [Full Text] [Related]

  • 16. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A, Ketas TJ, Nagashima KA, Zhao L, Cilliers T, Morris L, Moore JP, Maddon PJ, Olson WC.
    J Virol; 2001 Jan 30; 75(2):579-88. PubMed ID: 11134270
    [Abstract] [Full Text] [Related]

  • 17. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, Offord RE, Quiñones-Mateu ME, Arts EJ.
    J Virol; 2000 May 30; 74(10):4868-76. PubMed ID: 10775626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.